UNICA IRIS Institutional Research Information System

BALBONI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 155.617
NA - Nord America 14.082
AS - Asia 5.753
SA - Sud America 896
AF - Africa 136
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
Totale 176.515
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 152.263
US - Stati Uniti d'America 13.908
SG - Singapore 2.286
CN - Cina 1.865
UA - Ucraina 981
BR - Brasile 697
SE - Svezia 668
VN - Vietnam 494
GB - Regno Unito 424
FI - Finlandia 405
DE - Germania 303
FR - Francia 303
HK - Hong Kong 291
IN - India 195
KR - Corea 125
BD - Bangladesh 93
CA - Canada 92
RU - Federazione Russa 71
AR - Argentina 69
IQ - Iraq 51
MX - Messico 42
JP - Giappone 40
NL - Olanda 36
ID - Indonesia 35
PK - Pakistan 32
CO - Colombia 31
MA - Marocco 31
VE - Venezuela 31
ES - Italia 30
TR - Turchia 29
EC - Ecuador 28
AT - Austria 25
BE - Belgio 23
ZA - Sudafrica 22
UZ - Uzbekistan 21
AU - Australia 20
PH - Filippine 20
SA - Arabia Saudita 20
PL - Polonia 19
IL - Israele 17
KH - Cambogia 17
CL - Cile 16
JO - Giordania 15
NP - Nepal 14
KE - Kenya 13
KZ - Kazakistan 13
EG - Egitto 12
MU - Mauritius 12
MY - Malesia 12
JM - Giamaica 11
TN - Tunisia 11
DZ - Algeria 10
IE - Irlanda 10
AZ - Azerbaigian 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
LB - Libano 8
PY - Paraguay 8
TH - Thailandia 8
LT - Lituania 7
CR - Costa Rica 6
HU - Ungheria 6
NG - Nigeria 6
DO - Repubblica Dominicana 5
PS - Palestinian Territory 5
SN - Senegal 5
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
KW - Kuwait 2
LK - Sri Lanka 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
Totale 176.490
Salva come PNG Salva come JPEG
Città #
Cagliari 145.777
Uta 5.881
Fairfield 1.226
Singapore 1.175
Ashburn 1.109
Houston 1.040
Woodbridge 1.039
Chandler 978
San Jose 753
Boardman 738
Dallas 654
Ann Arbor 538
Wilmington 523
Jacksonville 521
Seattle 501
Cambridge 465
Nyköping 353
Beijing 255
Los Angeles 250
Hong Kong 244
Hefei 232
Helsinki 231
Council Bluffs 212
Nanjing 187
Boston 178
Lauterbourg 168
The Dalles 160
Santa Clara 150
Dearborn 132
Ho Chi Minh City 131
Buffalo 123
Seoul 117
Hanoi 108
San Diego 103
Shanghai 91
Milan 87
Dong Ket 66
Nanchang 57
Mountain View 56
Shenyang 56
Verona 53
Redwood City 52
Jiaxing 49
New York 49
Tianjin 49
London 48
Rome 47
Guangzhou 46
São Paulo 46
Chicago 45
Ferrara 45
Washington 43
Changsha 40
Pune 40
Frankfurt am Main 39
Hebei 38
Falls Church 35
Norwalk 34
Toronto 32
Sassari 28
Tokyo 28
Paris 27
Columbus 26
Jinan 26
Orange 26
Phoenix 24
Redondo Beach 24
Orem 23
Brooklyn 22
Ningbo 21
Saint Petersburg 21
Belo Horizonte 20
Tashkent 20
Baghdad 19
Rio de Janeiro 19
Atlanta 18
Nuremberg 18
Haiphong 17
Mexico City 17
Olbia 17
Phnom Penh 17
Brussels 16
Munich 16
Canberra 15
San Francisco 15
Zhengzhou 15
Amman 14
Casablanca 14
Jakarta 14
Hyderabad 13
Lahore 13
Tappahannock 13
Auburn Hills 12
Brasília 12
Chennai 12
Da Nang 12
Denver 12
Hangzhou 12
Quito 12
Warsaw 12
Totale 168.227
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.917
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.864
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors 2.842
Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain 2.811
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.735
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.714
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.665
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.603
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.601
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.588
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.531
Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment 2.482
Critical role for prokineticin 2 in CNS autoimmunity 2.463
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.368
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes 2.309
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity 2.288
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones 2.274
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.251
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 2.210
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy 2.209
Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo 2.102
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazoles 2.076
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 2.065
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.051
In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives 2.011
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.906
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 1.867
An important role for prokineticin 2 in autoimmune CNS demyelination 1.814
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.793
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.774
null 1.768
δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury 1.653
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 1.642
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 1.588
Genetically Encodable Bacterial Flavin Transferase for Fluorogenic Protein Modification in Mammalian Cells 1.584
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated 1.556
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors 1.525
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 1.484
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 1.462
Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior 1.402
null 1.383
Antagonism of EG-VEGF receptors is a novel targeted therapy for choriocarcinoma progression: in vitro, in vivo and in clinical studies 1.373
Ligand- and cell-dependent determinants and cAMP modulation by delta opioid receptor (DOR) agonists 1.355
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.351
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.335
A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation 1.316
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 1.287
The antagonism of the prokineticin system counteracts bortezomib induced side effects: Focus on mood alterations 1.282
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes 1.267
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.239
Prokineticin 1-prokineticin receptor 1 signaling promotes angiogenesis in the porcine endometrium during pregnancy 1.174
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.167
∂-opioid receptor activation protects against Parkinson’s disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy 1.155
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals 1.098
Opposite Roles of δ- and μ-Opioid Receptors in BACE1 Regulation and Alzheimer’s Injury 1.094
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy 1.055
Antidepressant-like and anxiolytic-like effects following activation of the mu-delta opioid receptor heteromer in the nucleus accumbens 956
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 912
δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes 878
Delta-opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia 869
Effect of delta-opioid receptor activation on BDNF-TrkB vs. TNF-Alpha in the mouse cortex exposed to prolonged hypoxia 856
activation of the mu-delta opioid receptor heteromer produces anti-depressant-like and anxiolytic-like effects 851
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 843
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 832
null 825
New features of the delta opioid receptor: conformationalproperties of deltorphin I analogues 818
Prokineticin receptors antagonist PC-10 as a biomarker for imaging inflammatory pain 813
Agonists at the delta-opioid receptor modify the binding of mu-receptor agonists to the mu-delta receptor hetero-oligomer 812
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 808
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis 742
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis 732
null 731
Conformational dynamics of KIR3.1/KIR3.2 channel activation via delta-opioid receptors (DORs) 731
Structural and biological exploration of Phe3-Phe4-modified endomorphin-2 peptidomimetics 725
Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors 725
Hair Growth Promotion by δ-Opioid Receptor Activation 718
Hydrogen sulfide inhibits inflammatory pain and enhances the analgesic properties of delta opioid receptors 710
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues. 687
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 686
DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex 681
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore 662
Na+ mechanism of delta-opioid receptor induced protection from K+ leakage in the cortex 637
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues 635
Role of the 2',6'-dimethyl-L-tyrosine (Dmt) in some opioid lead compounds 633
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance 631
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 630
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model 628
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors 616
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 610
Structure-activity relatioships of tetrapeptides related to dermorphin: a 500-MHz 1H-nmr study 584
A Critical Role of δ-Opioid Receptor in Anti-microglial Activation Under Stress 578
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 562
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 560
Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated 559
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice 558
null 546
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism 542
Prokineticin 1 is a novel factor regulating porcine corpus luteum function 538
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides 534
Synthesis of N-FmocN,N'-bis-Boc-5-,6- and 8-guanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid (5-GTIC, 6-GTIC and 8-GTIC) 534
Totale 136.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 257.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 257.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.519 0 0 0 0 0 0 0 0 0 0 0 1.519
2021/20229.546 600 806 1.092 529 420 819 912 643 595 587 934 1.609
2022/202316.522 1.658 1.741 1.164 1.262 1.464 2.157 1.168 1.527 978 1.019 1.601 783
2023/202419.214 725 818 712 1.288 1.898 3.050 3.230 1.222 924 1.297 1.763 2.287
2024/202539.798 8.850 11.727 5.060 4.256 2.362 2.242 3.438 216 421 314 361 551
2025/202610.332 606 578 1.421 759 666 648 1.493 818 936 1.656 629 122
Totale 177.102